SPCC and EURACAN Sign a Memorandum of Understanding
Sharing Progress in Cancer Care (SPCC) is pleased to announce a new collaboration with EURACAN, a consortium of 102 European expert centres, European Patients Advocates (ePAGs) and relevant stakeholders whose goal is to improve access to care and clinical excellence for patients with Rare Adult Solid Cancers (RASCs) across the European Union and Ukraine.
The partnership is formalised through a Memorandum of Understanding (MoU) signed in May 2025, marking a significant step towards advancing joint efforts in education and awareness around these challenging cancer types.
This agreement reflects our shared commitment to:
- Explore opportunities for co-developing educational content
- Exchange knowledge and resources
- Foster dialogue and joint initiatives in areas of common strategic interest
We are proud to stand alongside EURACAN in the pursuit of improving access to quality cancer care for patients affected by rare adult tumours across Europe.